Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To determine a difference in PFS by an Independent Review Committee (IRC) between lurbinectedin (PM01183)/DOX and a control arm consisting of best Investigator’s choice between CTX, DOX and VCR (CAV) or topotecan, as treatment in SCLC patients after failure of one prior platinum-containing line
Critère d'inclusion
- Small cell lung cancer (SCLC)